A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 15, Pages 8031-8047
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2016-01-30
DOI
10.1074/jbc.m115.698472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism
- (2015) Daisaku Yamada et al. HEPATOLOGY
- YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
- (2015) Patricia Marti et al. HEPATOLOGY
- New Mouse Models Mimic Biology of Human Cancer
- (2015) S. Charlie JNCI-Journal of the National Cancer Institute
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
- (2015) Francesca Zanconato et al. NATURE CELL BIOLOGY
- YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression
- (2015) C He et al. ONCOGENE
- NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway
- (2015) Sung Jun Bae et al. Nature Communications
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- YAP is a critical oncogene in human cholangiocarcinoma
- (2015) Tiemin Pei et al. Oncotarget
- YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
- (2015) Claudia Stein et al. PLoS Genetics
- New Mouse Models Mimic Biology of Human Cancer
- (2015) S. Charlie JNCI-Journal of the National Cancer Institute
- Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
- (2014) Xin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma
- (2014) Yun-Fei Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
- (2014) Rondell P. Graham et al. HUMAN PATHOLOGY
- Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation
- (2014) Jun Li et al. JOURNAL OF CLINICAL INVESTIGATION
- YAP activation is an early event and a potential therapeutic target in liver cancer development
- (2014) Andrea Perra et al. JOURNAL OF HEPATOLOGY
- The Biology of YAP/TAZ: Hippo Signaling and Beyond
- (2014) Stefano Piccolo et al. PHYSIOLOGICAL REVIEWS
- Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities
- (2014) Sumera Rizvi et al. SEMINARS IN LIVER DISEASE
- Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
- (2014) Mitesh J. Borad et al. PLoS Genetics
- HDAC6 Inhibition Restores Ciliary Expression and Decreases Tumor Growth
- (2013) S. A. Gradilone et al. CANCER RESEARCH
- Programming cancer cells for high expression levels of Mcl1
- (2013) Franziska Ertel et al. EMBO REPORTS
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Fibroblast growth factor signaling in liver carcinogenesis
- (2013) Dalbir S. Sandhu et al. HEPATOLOGY
- Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
- (2013) Yasuhito Arai et al. HEPATOLOGY
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
- (2013) Randy Johnson et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors
- (2012) G. J. Gores et al. GENES & DEVELOPMENT
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
- (2012) Shahid A Khan et al. GUT
- Comprehensive Method for Culturing Embryonic Dorsal Root Ganglion Neurons for Seahorse Extracellular Flux XF24 Analysis
- (2012) Miranda Lange et al. Frontiers in Neurology
- Molecular Profiling of Direct Xenograft Tumors Established from Human Pancreatic Adenocarcinoma After Neoadjuvant Therapy
- (2011) Michael P. Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
- (2011) Vito Guagnano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Deregulation of Hippo kinase signalling in Human hepatic malignancies
- (2011) Hua Li et al. LIVER INTERNATIONAL
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
- (2010) Nailing Zhang et al. DEVELOPMENTAL CELL
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
- (2009) James E. Everhart et al. GASTROENTEROLOGY
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
- (2009) Michael P Kim et al. Nature Protocols
- BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis
- (2008) J. L. Mott et al. MOLECULAR CANCER THERAPEUTICS
- Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage
- (2008) Dan Levy et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started